Neo Adjuvant Chemotherapy in Triple Negative Breast Cancer

计划入组 310 人 · 首次发布于 2010 年 1 月 27 日

Window of Opportunity Trial, PARP Inhibitor Rucaparib Affect on PD-L1 Expression in Triple Negative Breast Tumors

计划入组 20 人 · 首次发布于 2019 年 4 月 11 日

Liposomal Doxorubicin, Bevacizumab, and Everolimus in Patients With Locally Advanced TNBC With Tumors Predicted Insensitive to Standard Chemotherapy; A Moonshot Initiative

计划入组 17 人 · 首次发布于 2015 年 5 月 29 日

Triple-Negative Breast Cancer (formulated vaccine)

GPR161 antagonists (triple-negative breast cancer/sarcoma)

Triple-negative breast cancer(Divide and Conquer)

Triple-Gene LLC

United States

ANZ BREAST CANCER TRIALS GROUP LIMITED

Australia

JAPAN BREAST CANCER RESEARCH GROUP

Japan

CRISPR-KOALA Reveals 81 Hidden Genetic Drivers of Triple-Negative Breast Cancer in Living Tumors

Implantable Microparticles Deliver Dual Cancer Therapy, Eradicating Tumors in Mice

Implantable Microparticles Deliver Dual Cancer Therapy, Eradicating Tumors in Mice